Jennifer Datlof

Jennifer Datlof has held a variety of roles in the pharmaceutical industry since 1998. Jennifer began their career at Abbott as a Cardiovascular Specialty Representative, where they sold antihypertensive, hyperlipidemia, and NSAID products to cardiologists, internists, endocrinologists, orthopedic surgeons, and rheumatologists, with a focus on product launches, indication launches, and dosing launches. Jennifer then moved to Bayer Diagnostics as a Key Account Executive. In 2000, they joined Pharmacia as a Searle Team 2 Representative, selling COX-2 NSAIDs and migraine medications to orthopedic surgeons, rheumatologists, neurologists, and pain management physicians. From 2004 to 2007, they worked at Stiefel, a GSK company, as a Senior Sales Representative, selling dermatology and pediatric acne and rosacea medications. Jennifer then moved to Reckitt Benckiser (Indivior) as a Clinical Liaison, selling addiction medicine to psychiatrists, drug treatment centers, and internal medicine physicians, with a focus on a new delivery system/dosing launch. Finally, in 2022, they joined Alcresta Therapeutics as an Account Manager.

Jennifer Datlof attended the University of Florida from 1989 to 1991, Florida Atlantic University from 1991 to 1993, and Capital University Law School from 1993 to 1996, where they obtained a JD in Law.